About
Dr. David Weill has served on the TransMedics Board since April 2019.
Since 2016 he has been Principal of the Weill Consulting Group, a biomedical consulting group focusing on organ transplantation and lung disease, and has been involved in the transplant and advanced lung disease fields for over 20 years.
He served as Director of the Lung and Heart-Lung Transplant Program at Stanford University Medical Center from 2005 until 2016 and is the former Director of the Stanford Center for Advanced Lung Diseases; he holds a B.A. and M.D. from Tulane University.
Roles
TransMedics Group, Inc.
Director · Current role
April 2019–present
Stanford University Medical Center
Director of the Lung and Heart-Lung Transplant Program · Also former Director of the Stanford Center for Advanced Lung Diseases.
2005-2016
External Roles
Weill Consulting Group
Principal
2016-present
Director Compensation
FY 2025Fees earned or paid in cash
$71,000
Stock awards
$263,208
Total
$334,208
Also at TransMedics Group, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.